Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | mRNA |
Clinical data | |
Other names | SW 0123 |
Routes of administration | Intramuscular |
Identifiers | |
CAS Number |
Part of a series on the |
COVID-19 pandemic |
---|
|
COVID-19 portal |
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics.[2][3]